Metrics
31 Record Views
- Title
- PB2221: AN OPEN-LABEL, PHASE 1/1B STUDY TO EVALUATE THE SAFETY, PHARMACOKINETICS, PHARMACODYNAMICS AND CLINICAL ACTIVITY OF IMETELSTAT IN COMBINATION WITH RUXOLITINIB IN PATIENTS WITH MYELOFIBROSIS: IMPROVEMF
- Creators
- Andrew Kuykendall - Moffitt Cancer CenterTerrence Bradley - University of Miami Health SystemRami S. Komrokji - Moffitt Cancer CenterTymara Berry - GeronSouria Dougherty - GeronLaurie Sherman - GeronLixian Peng - GeronFei Huang - GeronYing Wan - GeronVivian Rodolf - GeronJudy Ho - GeronShyamala Navada - GeronJohn Mascarenhas - Icahn School of Medicine at Mount Sinai
- Publication Details
- HemaSphere, Vol.7, p.e906057e
- Academic Unit
- Miller School of Medicine; UMMG Dept of Medicine - Hematology/Oncology
- Language
- English
- Resource Type
- Journal article
- Record Identifier
- 991031923121002976